These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15041348)

  • 1. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
    Morozumi K; Takeda A; Uchida K; Mihatsch MJ
    Transplant Proc; 2004 Mar; 36(2 Suppl):251S-256S. PubMed ID: 15041348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cyclosporin nephropathy: long-term effects of cyclosporin on renal allografts.
    Takeda A; Uchida K; Haba T; Tominaga Y; Katayama A; Yoshida A; Oikawa T; Morozumi K
    Clin Transplant; 2001; 15 Suppl 5():22-9. PubMed ID: 11791791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
    Morozumi K; Thiel G; Albert FW; Banfi G; Gudat F; Mihatsch MJ
    Clin Nephrol; 1992 Jul; 38(1):1-8. PubMed ID: 1499163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X; Johnston A
    Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of cyclosporine A does not adversely impact on clinical outcomes following renal transplantation.
    Lewis RM
    Kidney Int Suppl; 1995 Dec; 52():S75-8. PubMed ID: 8587289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-induced renal dysfunction.
    Paul LC; de Fijter JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):224S-228S. PubMed ID: 15041342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity.
    Holzmacher R; Kendziorski C; Michael Hofman R; Jaffery J; Becker B; Djamali A
    Nephrol Dial Transplant; 2005 Jul; 20(7):1456-62. PubMed ID: 15840674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine-induced renal dysfunction in experimental animals and humans.
    Remuzzi G; Perico N
    Kidney Int Suppl; 1995 Dec; 52():S70-4. PubMed ID: 8587288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxic aspects of cyclosporine.
    Cattaneo D; Perico N; Gaspari F; Remuzzi G
    Transplant Proc; 2004 Mar; 36(2 Suppl):234S-239S. PubMed ID: 15041344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity?
    Takeda A; Morozumi K; Yoshida A; Uchida K; Tominaga Y; Fujinami T; Yokoyama I; Takagi H
    Transplant Proc; 1994 Apr; 26(2):925-8. PubMed ID: 8171705
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
    Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
    Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
    Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
    Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histological analysis of chronic tacrolimus nephrotoxicity in renal allografts.
    Shimizu T; Ishida H; Shirakawa H; Omoto K; Tanabe K; Yamaguchi Y
    Transplant Proc; 2008 Sep; 40(7):2370-2. PubMed ID: 18790237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
    Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M
    J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.